Wednesday, May 14, 2025 11:00:48 AM
Wow. Total bullshit. Seems as if you are the one that is full of Bunkum.
The conspiracy that someone at the FDA is against NWBO is bullshit. NWBO has time and time again failed to create a clear, logical, well run trial for DCVax-L. They morphed the P2 to a P3 because LP said it would be faster. How'd that work out?
They changed endpoints after they knew the original failed. The FDA did not approve the endpoint change. They simply did not reject it because it's a valid endpoint. That says nothing about NWBOs lack of ability to prove efficacy of this trial. What FDA does require is patient level data for an external control arm which Medicenna clearly stated after post P2 meetings with the FDA. They disclosed this because they aren't shady AF like NWBO. And that's why there is no BLA. LP can milk this MHRA bullshit for a long time so retail can buy more dead lotto ticket shares.
The conspiracy that someone at the FDA is against NWBO is bullshit. NWBO has time and time again failed to create a clear, logical, well run trial for DCVax-L. They morphed the P2 to a P3 because LP said it would be faster. How'd that work out?
They changed endpoints after they knew the original failed. The FDA did not approve the endpoint change. They simply did not reject it because it's a valid endpoint. That says nothing about NWBOs lack of ability to prove efficacy of this trial. What FDA does require is patient level data for an external control arm which Medicenna clearly stated after post P2 meetings with the FDA. They disclosed this because they aren't shady AF like NWBO. And that's why there is no BLA. LP can milk this MHRA bullshit for a long time so retail can buy more dead lotto ticket shares.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
